Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-13 · accession 0001104659-24-128688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-16 | 2024-12-13 | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $4.70 | +17.0K | 2.61M | +0.7% | +$79.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-13 | P | A | 17,000 | $4.70 | 2,612,000 | D | — | — |